INFORMATION BY CANCER TYPE

Ovarian

Feature Video
Sponsored Content: Dr. Shannon Westin on PARP Inhibition for Ovarian Cancer
Dr Shannon Westin, a clinical investigator at the MD Anderson Cancer Center, discusses PARP inhibition for patients with deleterious or suspected deleterious germline BRCA-mutated (as detected by an FDA-approved test) advanced ovarian cancer who have been treated with three or more prior lines of chemotherapy.
Learn to Speak Cancer's Foreign Language
BY Kelly Irvin
Cancer treatment may seem to involve a mysterious, unfathomable foreign language, but there are ways to improve those lines of communication.
Maintenance Lynparza Tablets Approved in Ovarian Cancer
Lynparza tablets (olaparib) tablets were granted FDA approval as a maintenance therapy for patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, who are in a complete or partial response to platinum-based chemotherapy.
Dr. Boulay Discusses Removing a 140-Pound Tumor
BY Richard Boulay, M.D.

Richard Boulay, M.D., chief of the division of Gynecologic Oncology at the Lehigh Valley Health Netowrk, tells the story of removing a 140-pound tumor from Mary Clancy. The tumor had been growing for at least 10 years when it was caught by a CAT scan, and was about half her body weight.
A Promising New Agent for Epithelial Ovarian Cancer
BY Danielle Bucco
A new agent showed a favorable toxicity profile for patients with epithelial ovarian cancer. The drug, mirvetuximab soravtansine (IMGN853), also demonstrated encouraging clinical activity in a phase 1 trial presented at the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting.
The Role of Genetic Testing in Ovarian Cancer
BY Danielle Bucco
Future treatment of ovarian cancer will include more interaction between molecular pathology and clinical pathology where genetic information can lead to more accurate pathologic diagnosis.
Cancer and Hair Loss Is More Than Physical
BY Kelly Irvin
Losing their hair is one more way that cancer makes patients feel they've lost control over their bodies. It's not just physical, it's personal. Here are some tips for what to say.
Lynparza Data Published as FDA Weighs Approval
BY Jason Harris
Positive clinical trial results are released at a critical moment in time.
Choice of Words Are Important for Cancer Ninjas
BY Kelly Irvin
I see myself as a cancer ninja. Other cancer patients might prefer a gentler word. Either way, words are important and the choice should be ours.
When Cancer Says
BY Kelly Irvin
Scoring the big NED often leads to that "Terminator" voice whispering in your ear.
Roadblocks to Advancing Treatment of Rare Ovarian Cancers
BY Allie Casey
CURE spoke with an expert on what is getting in the way of advancing treatment for rare types of ovarian cancer.
Special Feature
Share Your Art
Talk about this article with other patients, caregivers, and advocates in the Ovarian CURE discussion group.
Search Cancer Drugs & Terms
Treatment
Information about treatment, including surgery, chemotherapy, radiation therapy, immunotherapy, and vaccine therapy
Ovarian Epithelial Cancer Treatment (PDQ®)
Expert-reviewed information summary about the treatment of ovarian epithelial cancer.
Ovarian Epithelial, Fallopian Tube, and Primary Peritoneal Cancer Treatment (PDQ®)
Expert-reviewed information summary about the treatment of ovarian epithelial, fallopian tube, and primary peritoneal cancer treatment.
Ovarian Germ Cell Tumors Treatment (PDQ®)
Expert-reviewed information summary about the treatment of ovarian germ cell tumors.
Ovarian Low Malignant Potential Tumors Treatment (PDQ®)
Expert-reviewed information summary about the treatment of ovarian low-malignant potential tumors.
Prevention, Genetics, Causes
Information related to prevention, genetics, risk factors
Ovarian Cancer Prevention (PDQ®)
Expert-reviewed information summary about factors that may influence the risk of developing ovarian cancer and about research aimed at the prevention of this disease.
Screening and Testing
Information about methods of cancer detection including new imaging technologies, tumor markers, and biopsy procedures
Ovarian Cancer Screening (PDQ®)
Expert-reviewed information summary about tests used to detect or screen for ovarian cancer.
x